BHVN

Biohaven Pharmaceutical Holding Company Ltd.
BHVN

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BHVN was delisted on the 3rd of October, 2022.

Back to rankings

7 hedge funds and large institutions have $13.8M invested in Biohaven Pharmaceutical Holding Company Ltd. in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 228 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$10K
2
+$430

Top Sellers

1
-$748M
2
-$572M
3
-$537M
4
Stifel Financial
Stifel Financial
Missouri
-$464M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$349M
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$7.48M
2
$6.25M
3
$102K
4
$10K
5
$3K
6
$1K
7
$430
8
–
9
–
10
–
11
–
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–
1
2 3 4 5